Growth arrest of HPV-positive cells after histone deacetylase inhibition is independent of E6/E7 oncogene expression

Virology

Volumn 304, Issue 2, 2002, Pages 265-273

  Finzer, Patrick ^a   Ventz, Robert ^a   Kuntzen, Christian ^a   Seibert, Nadine ^a   Soto, Ubaldo ^a   Rösl, Frank ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cdk2 inhibition; Cervical cancer; p21; p27; Therapy

Indexed keywords

BETA ACTIN; BUTYRIC ACID; HISTONE DEACETYLASE; PROTEIN INHIBITOR; PROTEIN P21; PROTEIN P27; TRICHOSTATIN A;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; KERATINOCYTE; KINETICS; ONCOGENE; POLYADENYLATION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS TRANSMISSION; WART VIRUS;

EID: 0036939240     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1667     Document Type: Article

References (52)

1. Barbosa, M. S., and Schlegel, R. (1989). The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4, 1529-1532.
2. Blomberg, I., and Hoffmann, I. (1999). Ectopic expression of cdc25A accelerates the G1/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol. Cell. Biol. 19, 6183-6194.
3. Chen, T. A., Sterner, R., Cozzolino, A., and Allfrey, V. G. (1990). Reversible and irreversible changes in nucleosome structure along the c-fos and c-myc oncogenes following inhibition of transcription. J. Mol. Biol. 212, 481-493.
4. Chen, T.-M., Pecoraro, G., and Defendi, V. (1993). Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53, 1167-1171.
5. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidiniumthiocyanate-phenol/chloroform extraction. Anal. Biochem. 162, 156-159.
6. Dani, C., Mechti, N., Piechaczyk, M., Lebleu, B., Jeanteur, P., and Blanchard, J. M. (1985). Increased rate of degradation of c-mac mRNA in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82, 4896-4899.
7. Dean, P. N., and Jett, J. H. (1974). Mathematical analysis of DNA distributions derived from flow microfluorometry. J. Cell Biol. 60, 523.
8. Dürst, M., Petrussevska, R. T., Boukamp, P., Fusenig, N. E., and Gissmann, L. (1987). Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus 16 DNA. Oncogene 1, 251-256.
9. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vorgelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
10. Ercolani, L., Florence, B., Denaro, M., and Alexander, M. (1988). Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 263, 15335-15341.
11. Feinberg, A., and Vogelstein, B. A. (1984). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137, 266-267.
12. Finzer, P., Kuntzen, C., Soto, U., zur Hausen, H., and Rösl, F. (2001). Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 20, 4768-4776.
13. Francis, D. A., Schmid, S. I., and Howley, P. M. (2000). Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J. Virol. 74, 2679-2686.
14. Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., and Galloway, D. A. (1997). Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV 16 E7 oncoprotein. Genes Dev. 11, 2090-2100.
15. Goodwin, E. C., and DiMaio, D. (2000). Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA 97, 12513-12518.
16. Grant, P. A., and Berger, S. L. (1999). Histone acetyltransferase complexes. Semin. Cell Dev. Biol. 10, 169-177.
17. Gunning, P., Ponte, P., Okayama, H., Blau, H., and Kedes, L. (1983). Isolation and characterization of full-length cDNA clones for human α-, β-, and γ-actin mRNA: Skeletal but not cytoplasmic actins have an amino-terminal cystein that subsequently removed. Mol. Cell Biol. 3, 787-795.
18. Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., and Schiller, J. T. (1989). HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8, 3905-3910.
19. Hickman, E. S., Bates, S., and Vousden, K. H. (1997). Perturbation of the p53 response by human papillomavirus type 16 E7. J. Virol. 71, 3710-3718.
20. Jeon, S., Allen-Hoffmann, B. L., and Lambert, P. F. (1995). Integration of human papillomavirus type 16 into the human genome correlates with selective growth advantage of cells. J. Virol. 69, 2989-2997.
21. Jeon, S., and Lambert, P. F. (1995). Integration of human papillomavirus type 16 into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92, 1654-1658.
22. Jones, D. L., Alani, R. M., and Münger, K. (1997). The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21 Cip1-mediated inhibition of cdk2. Genes Dev. 11, 2101-2111.
23. Johnson, C. A., and Turner, B. M. (1999). Histone deacetylases: Complex transducers of nuclear signals. Sem. Cell Dev. Biol. 10, 179-188.
24. Khandjian, E. W., and Meric, C. (1986). A procedure for Northern blot analysis of native RNA. Anal. Biochem. 159, 227-232.
25. Kim, Y. B., Lee, K.-H., Sugita, K., Yoshida, M., and Horinouchi, S. (1999). Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. Oncogene 18, 2461-2470.
26. Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., and Kelly, W. K. (2001). Histone deacetylases and cancer: Cause and therapies. Nat. Rev. 1, 194-202.
27. Morozov, A., Shiyanov, P., Barr, E., Leiden, J. M., and Raychaudhuri, P. (1997). Accumulation of human papillomavirus type 16 E7 protein bypass G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21. J. Virol. 71, 3451-3457.
28. Münger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schlegel, R. (1989). The E6 and E7 genes of human papillomavirus type 16 are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63, 4417-4423.
29. Münger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M., and Zacny, V. L. (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-7898.
30. Ng, H. H., and Bird, A. (2000). Histone deacetylases: Silencers for hire. Trends Biochem. Sci. 25, 121-126.
31. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
32. Rösl, F., Westphal, E.-M., and zur Hausen, H. (1989). Chromatin structure and transcriptional regulation of human papillomavirus type 18 DNA in HeLa cells. Mol. Carcinog. 2, 72-80.
33. KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene 18, 1663-1676.
34. Schiller, J. T. (1999). Papillomavirus-like particle vaccines for cervical cancer. Mol. Med. Today 5, 209-215.
35. Shi, Y., Lee, J. S., and Galvin, K. M. (1997). Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332, 49-66.
36. Soto, U., Das, B. C., Lengert, M., Finzer, P., zur Hausen, H., and Rösl, F. (1999). Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 18, 3187-3198.
37. Steele, C., Cowsert, L. M., and Shillitoe, E. J. (1993). Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res. 53, 2330-2337.
38. Stein, G. H., Drullinger, L. F., Soulard, A., and Dulic, V. (1999). Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell Biol. 19, 2109-2117.
39. Stoehr, M., Vogt-Schaden, M., Knobloch, M., Vogel, R., and Futterman, G. (1978). Evaluation of eight fluorochrome combinations for simultaneous DNA-protein flow analysis. Stain Technol. 55, 205-215.
40. Van Lint, C., Emiliani, S., and Verdin, E. (1996). The expression of a small fraction of cellular genes is changed in response to histone hyper-acetylation. Gene Expr. 5, 245-253.
41. Vaziri, C., Stice, L., and Faller, D. V. (1998). Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 9, 465-474.
42. Villa, L. L., and Schlegel, R. (1991). Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology 181, 374-377.
43. von Knebel Doeberitz, M., Oltersdorf, T., Schwarz, E., and Gissmann, L. (1988). Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 48, 3780-3786.
44. von Knebel Doeberitz, M., Rittmüller, C., zur Hausen, H., and Dürst, M. (1992). Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 antisense RNA. Int. J. Cancer 51, 831-834.
45. von Knebel Doeberitz, M., Rittmüller, C., Aengeneyndt, F., Jansen-Dürr, P., and Spitkovsky, D. (1994). Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: Consequences for the phenotype and E6-p53 and E7-pRB interactions. J. Virol. 68, 2811-2821.
46. Warrell, R. P., He, L.-Z., Richom, V., Calleja, E., and Pandolfi, P. P. (1998). Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. 90, 1621-1625.
47. Workman, J. L., and Kingston, R. E. (1998). Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67, 545-579.
48. Yao, Y.-L., Yang, W.-M., and Seto, E. (2001). Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21, 5979-5991.
49. CIP1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene 18, 103-115.
50. Zhao, W., Noya, F., Chen, W. Y., Townes, T. M., Chow, L. T., and Broker, T. R. (1999). Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. J. Virol. 73, 5026-5033.
51. KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogenes 13, 2323-2330.
52. zur Hausen, H. (2000). Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92, 690-698.